{"url_path":"/sec/allo/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1737287/0001628280-26-034585-index.html","accession_number":"0001628280-26-034585","cik":"0001737287","ticker":"ALLO","issuer_name":"Allogene Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1737287/0001628280-26-034585-index.html","primary_entity_key":"0001737287","primary_entity_name":"Allogene Therapeutics, Inc."},"word_count":417,"has_tables":true,"body_markdown":"Item 6.    Exhibits.\n\nExhibit\n\nnumber\nDescription of document\n\n3.1\n[Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-38693), filed with the SEC on October 15, 2018).](https://www.sec.gov/Archives/edgar/data/1737287/000119312518299356/d622265dex31.htm)\n\n3.2\n[Certificate of Amendment of Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-38693), filed with the SEC on June 17, 2022).](https://www.sec.gov/Archives/edgar/data/1737287/000173728722000039/allo-20220617x8kxexhibit31.htm)\n\n3.3\n[Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K (File No. 001-38693), filed with the SEC on October 15, 2018).](https://www.sec.gov/Archives/edgar/data/1737287/000119312518299356/d622265dex32.htm)\n\n4.1\nReference is made to Exhibits [3.1](https://www.sec.gov/Archives/edgar/data/1737287/000119312518299356/d622265dex31.htm), [3.2](https://www.sec.gov/Archives/edgar/data/1737287/000173728722000039/allo-20220617x8kxexhibit31.htm) and [3.3](https://www.sec.gov/Archives/edgar/data/1737287/000119312518299356/d622265dex32.htm).\n\n4.2\n[Form of Common Stock Certificate of the Registrant (incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-227333), filed with the SEC on October 2, 2018).](https://www.sec.gov/Archives/edgar/data/1737287/000119312518290441/d548088dex41.htm)\n\n10.6+\n[Consulting Agreement, effective as of August 9, 2018, by and between the Registrant and Bellco Capital LLC, as amended.](allo-20260331xex106.htm)\n\n31.1\n[Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.](allo-20260331xex311.htm)\n\n31.2\n[Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.](allo-20260331xex312.htm)\n\n32.1\n[Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](allo-20260331xex321.htm)\n\n101.INSXBRL Instance Document - The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.\n\n101.SCHInline XBRL Taxonomy Extension Schema Document.\n\n101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.\n\n101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.\n\n101.LABInline XBRL Taxonomy Extension Label Linkbase Document.\n\n101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.\n\n104The cover page from the Company’s Quarterly Report on Form 10-Q has been formatted in Inline XBRL.\n\n+ Indicates management contract or compensatory plan.\n\n83\n\n[Table of Contents](#i458e61a10e714873b386bdbeb7020a31_7)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nDate: May 13, 2026By:/s/ David Chang\n\nDavid Chang, M.D., Ph.D.\n\nPresident and Chief Executive Officer\n\n(Principal Executive Officer)\n\nDate: May 13, 2026By:/s/ Geoffrey Parker\n\nGeoffrey Parker\n\nChief Financial Officer\n\n(Principal Financial Officer)\n\n84"}